Related Experiment Video
Updated: Jan 8, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Prevalence and associated factors of post-tuberculosis lung disease in Sub-Saharan Africa: a systematic review and
Abraham Tekola Gebremedhn1, Kidist Bobosha2, Yeabsira Alemu Fantaye2
1Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia. abratekola@gmail.com.
Background:
Post-tuberculosis lung disease (PTLD) is a major public health challenge in sub-Saharan Africa (SSA), where the burden of tuberculosis (TB) remains high. Only a few studies have reported the global burden of PTLD, and the associated factors of PTLD have been understudied. This systematic review and meta-analysis aimed to estimate the pooled prevalence and associated factors of PTLD in SSA.
Methods:
This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines for systematic review and meta-analysis. We included studies reporting the prevalence and associated factors of PTLD among individuals with a history of pulmonary TB in SSA. A comprehensive literature search was conducted via PubMed, Embase, Google Scholar, and African Journal Online databases from February 25, 2025, to March 20, 2025. The pooled prevalence of PTLD was estimated using a random-effects model. Due to the lack of reports on adjusted odds ratios (aORs), the associated factors were analyzed using crude odds ratios (ORs).
Results:
A total of 21 studies, consisting of 4,463 participants, were included. The overall pooled prevalence of PTLD in SSA was 43.26% (95% CI: 34.17%-52.34%). The key Factors significantly associated with PTLD included: female sex (OR: 1.57, 95% CI: 1.16, 2.11), smoking (OR: 1.64, 95% CI: 1.09, 2.46), Presence of cough (OR: 1.73, 95% CI: 1.03, 2.9) and fibrotic pattern (OR:3.94 (95% CI: 1.96, 7.92).
Conclusion:
Nearly half of prior TB patients in SSA develop PTLD. Being female, smoking, fibrosis, and post-treatment cough were key factors associated with PTLD. To effectively manage PTLD in SSA, it is important to implement targeted interventions for high-risk groups, strengthen screening and chronic care services, enhance healthcare system capacity, ensure equity in health resources and integrate PTLD management into national TB control programs.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders

